Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History

Jane Street’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,100	Closed	-$103K	–	13159
2025 Q4	$103K	Sell	13,100 -24,600	-65%	-$194K	﹤0.01%	10174
2025 Q3	$307K	Buy	37,700 +19,300	+105%	+$128K	﹤0.01%	8856
2025 Q2	$85.9K	Buy	18,400 +5,300	+40%	+$24.3K	﹤0.01%	9013
2025 Q1	$71.9K	Buy	+13,100	New	+$52.9K	﹤0.01%	8918
2022 Q3	–	Sell	-71,800	Closed	-$111K	–	10590
2022 Q2	$111K	Sell	71,800 -15,000	-17%	-$31.7K	﹤0.01%	8580
2022 Q1	$222K	Sell	86,800 -106,200	-55%	-$259K	﹤0.01%	8892
2021 Q4	$565K	Buy	193,000 +29,600	+18%	+$63.9K	﹤0.01%	7030
2021 Q3	$400K	Sell	163,400 -119,300	-42%	-$346K	﹤0.01%	7684
2021 Q2	$1.15M	Buy	282,700 +105,900	+60%	+$404K	﹤0.01%	5537
2021 Q1	$797K	Buy	176,800 +84,200	+91%	+$454K	﹤0.01%	5896
2020 Q4	$456K	Buy	+92,600	New	+$463K	﹤0.01%	5883

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jane Street's XERS Position: Q2 2026 in Review

Jane Street reduced its Xeris Biopharma Holdings (XERS) stake by 91% in Q2 2026, selling an estimated $4.24M and leaving 61,915 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #8077.

Jane Street first reported a position in XERS in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.44M in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Jane Street held 61,915 shares of Xeris Biopharma Holdings worth $490K as of Q2 2026.
Jane Street sold 663,701 Xeris Biopharma Holdings shares in Q2 2026, an estimated $4.24M.
Xeris Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8077 holding.
Jane Street first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 23 quarters since.
Jane Street's Xeris Biopharma Holdings position peaked at $7.44M in Q3 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.